Biosynch.ai
Biosynch.ai accelerates discovery and development of new medicines using AI and computational biology. The company combines advanced machine learning models, multi-omics and clinical data integration, and an integrated wet lab to design molecules optimized for efficacy, safety, and manufacturability. Its AI-native platform serves research scientists and pharmaceutical partners, leveraging AI/ML, computational biology, and extensive biological datasets including real-world evidence. Biosynch.ai focuses on oncology, neuroscience, immunology, and rare diseases and advances therapeutic candidates through end-to-end product development.
Biosynch.ai
Biosynch.ai accelerates discovery and development of new medicines using AI and computational biology. The company combines advanced machine learning models, multi-omics and clinical data integration, and an integrated wet lab to design molecules optimized for efficacy, safety, and manufacturability. Its AI-native platform serves research scientists and pharmaceutical partners, leveraging AI/ML, computational biology, and extensive biological datasets including real-world evidence. Biosynch.ai focuses on oncology, neuroscience, immunology, and rare diseases and advances therapeutic candidates through end-to-end product development.